Back to Search
Start Over
GSK announces regulatory filing once-daily closed triple combination therapy FF/UMEC/VI for patients with COPD
- Source :
- M2 Pharma. November 22, 2016
- Publication Year :
- 2016
-
Abstract
- M2 PHARMA-November 22, 2016-GSK announces regulatory filing once-daily closed triple combination therapy FF/UMEC/VI for patients with COPD (C)2016 M2 COMMUNICATIONS Pharmaceutical company GlaxoSmithKline plc (LSE:GSK)(NYSE:GSK) said on Monday that it [...]
Details
- Language :
- English
- Database :
- Gale General OneFile
- Journal :
- M2 Pharma
- Publication Type :
- News
- Accession number :
- edsgcl.471004687